CD69 and glioblastoma: However, we saw a significant reduction in the percentage of CD69 and IFNγ positivity in PMA and ionomycin-stimulated CD4+ and CD8+ T cells and NK cells from glioblastoma patients compared to their counterparts in healthy donors [35].